Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Omeros Corporation - Common Stock (NQ:OMER)

7.910 -0.310 (-3.77%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Omeros Corporation - Common Stock

< Previous 1 2 3 4 5 6 Next >
Earnings Scheduled For March 31, 2025
Via Benzinga
What's Next: Omeros's Earnings Preview
Via Benzinga
Earnings Scheduled For November 13, 2024
Via Benzinga
Earnings Outlook For Omeros
Via Benzinga
OMER Stock Earnings: Omeros Misses EPS for Q2 2024
OMER stock results show that Omeros missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
OMER Stock Earnings: Omeros Misses EPS for Q1 2024
OMER stock results show that Omeros missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Top Wall Street Forecasters Revamp Omeros Price Expectations Ahead Of Q4 Earnings
Via Benzinga
Incyte, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Why Precision BioSciences Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
This Omeros Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
OMER Stock Earnings: Omeros Misses EPS for Q4 2023
OMER stock results show that Omeros missed analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Nasdaq Jumps 100 Points, US Initial Jobless Claims Decline
Via Benzinga
Omeros Antibody Improves Overall Survival In Rare Complication After Stem Cell Transplant, Stock Surges
Omeros announces positive results from a pivotal narsoplimab trial in TA-TMA, showing significant survival benefits and advancing regulatory submissions. 
Via Benzinga
Gold Falls Sharply, Lamb Weston Shares Plunge
Via Benzinga
Accenture Posts Upbeat Results, Joins Darden Restaurants, CarMax And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Jim Cramer Prefers FedEx Over This Delivery Giant That 'Screwed Up A Lot Of Holiday Seasons'
Via Benzinga
Natural Grocers By Vitamin Cottage, Elastic, Matthews International, Gap And Other Big Stocks Moving Higher On Friday
Via Benzinga
Neurogene, Nvidia And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Crude Oil Moves Higher; Deere Cuts Profit Outlook
Via Benzinga
Exposures Fossil Fuels
Why Fluent Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
US Stocks Edge Higher; Initial Jobless Claims Fall
Via Benzinga
Earnings Scheduled For April 1, 2024
Companies Reporting Before The Bell • Mach Natural Resources (NYSE:MNR) is projected to report quarterly earnings at $0.92 per share on revenue of $213.43 million. 
Via Benzinga
Investor Sentiment Edges Lower, US Stocks Record Gains Last Quarter
The CNN Money Fear and Greed index showed a slight decline in overall market sentiment, but it remained in the "Greed" zone on Thursday. U.S. stocks closed mixed on Thursday, while the S&P 500 surged... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Sleeping Giants: 3 Picks With Massive Upside by Mid-Decade
Discover three stocks with massive upside in oil and gas, data processing and outsourcing services, and pharmaceuticals sectors. 
Via InvestorPlace
Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday
U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday. 
Via Benzinga
Topics Stocks
Exposures US Equities
3 Sleeper Stocks Under $15 Ready to Explode by 2029
Discover 3 under-$15 stocks primed for a 2029 explosion, from fintech disruptors to biotech pioneers tackling untreatable rare diseases. 
Via InvestorPlace
7 Short-Squeeze Stocks That Are Screaming for Speculation
If you like to march to your own beat even against high pressure, these short-squeeze stocks could be right for you. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.